Publications by authors named "Elsa Gomez-Escobar"

Claim this Profile
E
Erratum: One step closer to a pan-genotypic hepatitis C vaccine.
Elsa Gomez-Escobar, Nicol Flores, Naglaa H Shoukry

Hepatology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One step closer to a pan-genotypic hepatitis C vaccine.
Elsa Gomez-Escobar, Nicol Flores, Naglaa H Shoukry

Hepatology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 T cells take center stage during dengue infection.
Elsa Gomez-Escobar, Naglaa H Shoukry

Cell Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation-Induced Marker Assay to Identify and Isolate HCV-Specific T Cells for Single-Cell RNA-Seq Analysis.
Mohamed Eisa, Nicol Flores, Omar Khedr, Elsa Gomez-Escobar, Nathalie Bédard

Viruses· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated expansion of memory T follicular helper and B cells mediates spontaneous clearance of HCV reinfection.
Mohamed Eisa, Elsa Gomez-Escobar, Nathalie Bédard, Nourtan F Abdeltawab, Nicol Flores

Front Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies.
Elsa Gomez-Escobar, Philippe Roingeard, Elodie Beaumont

Viruses· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impacts of the COVID-19 pandemic on hepatitis C elimination in Canada: Where do we go from here?
Jawairia Atif, Sasha Tejna Persaud Udhesister, Mohamed N Abdelnabi, Simmone D'Souza, Jui-Hsia Hung, Elsa Gomez-Escobar

Can Liver J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporation of apolipoprotein E into HBV-HCV subviral envelope particles to improve the hepatitis vaccine strategy.
Elsa Gomez-Escobar, Julien Burlaud-Gaillard, Clara Visdeloup, Adeline Ribeiro E Silva, Pauline Coutant

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixing particles from various HCV genotypes increases the HBV-HCV vaccine ability to elicit broadly cross-neutralizing antibodies.
Elodie Beaumont, Benoit Joël Clément, Vanessa Guérin, Lucie Chopin, Emmanuelle Roch, Elsa Gomez-Escobar

Liver Int· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis